- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03019913
Evaluation of Bedside Methods to Measure Muscularity in Critically Ill Patients
Evaluation of Bedside Methods to Measure Muscularity in Critically Ill Patients: A Prospective Observational Study
Muscle wasting is a significant problem in critically ill patients, with reported losses of a half to three percent per day over the first ten days (for an average 70kg person this equates to 3 to 20kg of muscle loss). Low skeletal muscle mass at admission to the intensive care unit (ICU) and the loss of lean tissue have been associated with negative clinical outcomes, including increased incidence of infections, length of stay, mortality and muscle weakness. It is therefore crucial that technology is utilised to: 1) identify ICU patients with low muscularity on admission, 2) to help understand the factors impacting muscle loss and to 3) assess the effectiveness of interventions aimed at maintaining skeletal muscle mass in this population.
The measurement of lean body mass in patients admitted to the ICU is challenging however, due to the large fluid shifts that occur in this population and logistical issues in moving patients to specialised machinery for body composition analysis. Currently, there is no validated method for accurately assessing a patient's muscle mass at the bedside in the intensive care setting. It is therefore important to investigate the accuracy, feasibility and reliability of bedside methods such as subjective physical assessment of muscle mass, mid arm muscle circumference, ultrasound and bioimpedance analysis to assess muscularity in this population who are primarily bedbound. In order to do this, a critical comparison is required between these methods and muscularity assessed by a "reference" body composition method, such computed tomography (CT) image analysis. Briefly, quantification of skeletal muscle at the abdomen area utilising abdominal CT images has been shown to be highly representative of whole body skeletal muscle volume.
We wish to conduct a pilot, feasibility study (n= 50), which will recruit patients who have a CT scan (containing abdomen area), performed for clinical purposes. Our primary aim will be to investigate whether muscularity assessed with non-invasive bedside methods (ultrasound, bioimpedance analysis, SGA physical assessment, mid arm muscle circumference) are correlated with skeletal muscle mass quantified by a "reference method" (CT image analysis).
Studieoversikt
Detaljert beskrivelse
Aim Our primary aim is to investigate whether muscularity assessed via bedside ultrasound is correlated with a reference method for estimating whole body skeletal muscle mass (CT image analysis) in the first few days of critical illness.
Our secondary aims are
- To investigate whether muscularity assessed via other bedside methods (bioimpedance spectroscopy, subjective physical assessment and mid arm muscle circumference) are correlated with a reference method for estimating whole body skeletal muscle mass (CT image analysis) in critically ill patients.
- To better understand the association between measured resting energy expenditure and muscularity in the critically ill.
- To observe changes in skeletal muscle mass (in a sub set of patients who have two CT scans) and the impact various factors, including energy and protein delivery has on these changes.
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
Victoria
-
Melbourne, Victoria, Australia, 3004
- The Alfred Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- Have had a CT scan of the L3 vertebra performed for clinical reasons ≤24 hours before or ≤72 hours after ICU admission
Exclusion Criteria:
- CT scan performed >48hrs ago
- Death is imminent or deemed highly likely in the next 96 hours
- Are known to be pregnant
- Treating clinician does not believe the study to be in the best interest of the patient
- It is not possible to image two or more muscle groups via ultrasound (i.e. due to trauma, burns, wounds)
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Mean skeletal muscle mass measured by CT scan analysis at L3 area (cm2)
Tidsramme: CT performed for clinical reasons ≤24 hours before or ≤72 hours after ICU admission
|
CT performed for clinical reasons ≤24 hours before or ≤72 hours after ICU admission
|
|
Mean skeletal muscle mass measured by ultrasound (muscle thickness at each site, cm and rectus femoris CSA, cm2)
Tidsramme: <48 hours after CT scan containing L3 area
|
<48 hours after CT scan containing L3 area
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Fat free mass (kg), phase angle and impedance ratio measured by bioimpedance spectroscopy
Tidsramme: <48 hours after CT scan containing L3 area
|
<48 hours after CT scan containing L3 area
|
|
Subjective assessment of muscle and fat wasting via SGA (normal, mild-moderate or severe)
Tidsramme: <48 hours after CT scan containing L3 area
|
<48 hours after CT scan containing L3 area
|
|
Mid arm muscle circumference (cm)
Tidsramme: <48 hours after CT scan containing L3 area
|
<48 hours after CT scan containing L3 area
|
|
Mean skeletal muscle mass measured by CT scan analysis at femoral area (cm2)
Tidsramme: CT performed for clinical reasons ≤24 hours before or ≤72 hours after ICU admission
|
CT performed for clinical reasons ≤24 hours before or ≤72 hours after ICU admission
|
|
Measured resting energy expenditure (kilojoules)
Tidsramme: <48 hours after CT scan containing L3 area
|
<48 hours after CT scan containing L3 area
|
|
Intramuscular, subcutaneous and visceral adipose tissue CSA at L3 area (cm2)
Tidsramme: CT performed for clinical reasons ≤24 hours before or ≤72 hours after ICU admission
|
CT performed for clinical reasons ≤24 hours before or ≤72 hours after ICU admission
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Kate Lambell, MNutrDiet, La Trobe University and Alfred Health
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 523/16
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Kritisk sykdom
-
Unity Health TorontoUkjentUtdanning, medisinsk | Critical Care UltrasonographyCanada
-
Unity Health TorontoFullført
-
Nanjing PLA General HospitalFullførtCritical Care Pasient; Nedre fordøyelseskanal lidelse; | Tykktarmslesjoner;
-
Heidelberg UniversityUkjentSedering av cerebrovaskulær ventilerte Critical Care-pasienterTyskland
-
National Taiwan University Clinical Trial CenterRekrutteringKardiologi, Critical Care Medicine, Emergency Medical ServiceTaiwan
Kliniske studier på Observational cohort
-
Clinical Research Centre, MalaysiaHospital Queen Elizabeth, MalaysiaAvsluttetCovid-19 | Kritisk sykMalaysia
-
Abramson Cancer Center at Penn MedicineRekrutteringAllogen transplantasjonForente stater
-
University of Alabama at BirminghamEunice Kennedy Shriver National Institute of Child Health and Human Development...Påmelding etter invitasjonSeksuelt overførbare sykdommer | HivForente stater
-
The Second Affiliated Hospital of Shandong First...Har ikke rekruttert ennåNeoplasmer i bukspyttkjertelen | Neoplasmer i galleveiene
-
Centre Hospitalier William Morey - Chalon sur SaôneCentre Hospitalier Universitaire Dijon; Centre Hospitalier MaconRekrutteringBakteremi | Tomografi, optisk koherens | Biofilmer | Arteriell kateterisering, perifertFrankrike
-
Telix Pharmaceuticals (Innovations) Pty LimitedSpecialty Networks Research.AvsluttetProstatakreft (Adenocarcinoma)Forente stater
-
St. Louis UniversityRekrutteringVertebral arteriestenoseForente stater
-
Prana Biotechnology LimitedFullførtFriske FrivilligeAustralia
-
Bristol-Myers SquibbCardioxyl Pharmaceuticals, IncFullførtHjertefeilForente stater
-
Mayo ClinicRekrutteringOndartet fast neoplasma | Neoplasma i hematopoetisk og lymfatisk systemForente stater